netFormulary Tayside Area Formulary NHS
 
 Search
 Formulary Chapter 6: Endocrine system - Full Section
 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
06.01 Drugs used in diabetes (0,0)
06.01.01 Insulins (1,1)
06.01.02 Antidiabetic drugs (0,0)
06.01.02.01 Biguanides (1,0)
06.01.02.02 Sulphonylureas (3,2)
06.01.02.03 Thiazolidinediones (2,0)
06.01.02.04 Dipeptidylpeptidase-4 inhibitors (4,6)
06.01.02.05 Glucagon-like peptide-1 receptor agonists (2,2)
Glucagon-like peptide-1 receptor agonists - once weekly (2,2)
06.01.02.06 Sodium-glucose co-transporter 2 inhibitors (4,3)
06.01.02.07 Other antidiabetic drugs (1,2)
06.01.03 Diabetic ketoacidosis (0,0)
06.01.04 Treatment of hypoglycaemia (3,0)
06.01.06 Diagnostic and monitoring agents for diabetes mellitus (0,0)
Blood glucose monitoring (0,0)
Urinalysis (0,0)
Oral glucose tolerance test (2,0)
06.02 Thyroid and Antithyroid drugs (0,0)
06.02.01 Thyroid hormones (2,2)
06.02.02 Antithyroid drugs (3,0)
06.03 Corticosteroids (0,0)
06.03.01 Replacement therapy (1,0)
06.03.02 Glucocorticoid therapy (4,2)
Pregnancy and breastfeeding (0,0)
06.04 Sex hormones (0,0)
06.04.01 Female sex hormones (0,0)
06.04.01.01 Oestrogens and HRT (1,1)
Oestrogen only HRT (4,0)
Combined sequential HRT (4,0)
Combined continuous HRT (5,0)
Testosterone (1,0)
06.04.01.02 Progestogens and progesterone receptor modulators (3,2)
06.04.02 Male sex hormones and antagonists (6,2)
Anti-androgens (1,0)
06.05 Hypothalamic and pituitary hormones and anti-oestrogens (0,0)
06.05.01 Hypothalamic and anterior pituitary hormones and anti-oestrogens (0,0)
Anti-oestrogens (1,0)
Anterior pituitary hormones (1,0)
Gonadotrophins (0,1)
Growth Hormone (1,0)
Growth hormone receptor antagonists (0,0)
Thyrotropin (1,0)
Hypothalmic hormones (1,0)
06.05.02 Posterior pituitary hormones and antagonists (0,0)
Posterior pituitary hormones (2,1)
Selective vasopressin V2-receptor antagonists (1,1)
06.06 Drugs affecting bone metabolism (0,0)
Raloxifene (1,0)
06.06.01 Calcitonin and parathyroid hormone (2,0)
06.06.02 Bisphosphonates and other drugs affecting bone metabolism (0,0)
Bisphosphonates (7,6)
Denosumab (2,0)
Strontium ranelate (0,1)
06.07 Other endocrine drugs (0,0)
06.07.01 Bromocriptine and other dopaminergic drugs (3,0)
06.07.02 Drugs affecting gonadotrophins (0,0)
Gonadorelin analogues (2,3)
06.07.03 Cushing's Syndrome (1,1)
netFormulary